admin,  —

Articles by

8 Scleroderma-Related Conditions You Should Look Out For

According to the Scleroderma Foundation, here’s some scleroderma-related conditions you should look out for: 1 – Gastrointestinal Issues Individuals living with systemic scleroderma may grow some irregularities from the mouth to the anal canal of the digestive system and gastrointestinal tract. Also, thickening and fibrosis (or scarring) of the tissues…

Meet the Chefs from the 8th Annual Food Fight for Scleroderma

The 8th annual Food Fight for Scleroderma benefiting the Scleroderma Foundation, Greater Chicago Chapter will be held on April 10, 2016, in Chicago. Learn more about scleroderma here: http://bit.ly/learnscleroderma Meet chef Jason Paskewitz who is joining the cause.   Meet chef Lamar Moore who is joining the…

What is Research Doing for Me? What New Therapies Can I Try?

In this FESCA video from the Patient Congress at the 4th Systemic Sclerosis World Congress, Lisbon 2016, listen to the following presentations: Prof. C. Denton: “The Hope of Systemic Drugs” Prof. J. Van Laar: “Considering Stem-Cell Transplants” A. Martin: “My Lung Transplant” R. Kanters: “My Stem-Cell Transplant” Learn more…

Last Week’s Hot Topic on Scleroderma

Last week’s hot topic on Scleroderma was about the Spotlight on the Ssc patient: Alice Martins Correia; Geneva, Switzerland, written by Nicola Whitehill. The article focuses on the amazing story of Maria Alice Martins Correia from Geneva, Switzerland. Alice is, without doubt, one of the bravest pioneering…

Medical Research and the Scleroderma Research Foundation

In this short clip, Dr. Hal Dietz, Professor of Genetics & Medicine and Director of the Smilow Center for Marfan Syndrome Research at The Johns Hopkins University School of Medicine, discusses medical research and the work of the Scleroderma Research Foundation. Learn more about scleroderma here:…

Just Launched: Journal of Scleroderma and Related Disorders

The European Scleroderma Trials and Research group (EUSTAR) and the World Scleroderma Foundation recently announced the launch of a scholarly journal dedicated to coverage of research and clinical data regarding systemic sclerosis (SSc) and related autoimmune and fibrotic diseases, called the Journal of Scleroderma and Related Disorders (JSRD). Read…

Emerging Therapies for Pulmonary Fibrosis for Scleroderma Patients

Dr. Paul Wolters, Director of Biological Research for the Interstitial Lung Disease Program at the University of California, San Francisco (UCSF) – “Emerging Therapies in Pulmonary Fibrosis: Their Relevance for Scleroderma Patients” will educate a broad audience on the diagnosis and importance of early management of scleroderma.